|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.40 EUR | -0.68% |
|
+9.55% | +72.91% |
| 04/12 | Evotec's Partner Bayer Starts Mid-stage Study of Genetic Kidney Disease Drug | MT |
| 04/12 | Bayer Starts Phase IIa Study for Treatment of Patients with Alport Syndrome | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.33% | 1.62% | 78x | 0.99x | 1.41x | 6.76x | 12.19x | 3.81TCr | ||
| 0.59% | 0.66% | 44.17x | 33.26x | 14.63x | 32.47x | 34.87x | 90TCr | ||
| 2.56% | 2.64% | 19.27x | 6.19x | 5.41x | 14.97x | 16.42x | 49TCr | ||
| 2.89% | 3% | 52.81x | -545.82x | 7.48x | 17.71x | 18.22x | 40TCr | ||
| 3.18% | 3.24% | 18.03x | 6.44x | 4.54x | 11.37x | 12.9x | 33TCr | ||
| 1.78% | 1.88% | 27.29x | 6.16x | 5.16x | 15.31x | 16.13x | 28TCr | ||
| 3.07% | 3.2% | 18.36x | 5.75x | 4.97x | 11.67x | 12.58x | 26TCr | ||
| 3.24% | 3.39% | 12.89x | 4.6x | 4.21x | 9x | 10.17x | 25TCr | ||
| 3.76% | 3.73% | 13.42x | 7.33x | 4.8x | 9.94x | 11.49x | 21TCr | ||
| 2.9% | 3.06% | 25.21x | 19.93x | 6.12x | 10.51x | 14.04x | 18TCr | ||
| 2.73% | 2.85% | 17.68x | 6.63x | 5.58x | 10.21x | 12.28x | 15TCr | ||
| 6.55% | 6.69% | 13.48x | 1.64x | 3.02x | 7.58x | 8.74x | 15TCr | ||
| 4.89% | 5.05% | 12.36x | 1.32x | 2.66x | 8.65x | 9.63x | 12TCr | ||
| -.--% | -.--% | 29.33x | 6.19x | 8.88x | 19.18x | 19.93x | 12TCr | ||
| 4.74% | 4.88% | 12.32x | 5.36x | 2.91x | 8.45x | 8.81x | 11TCr | ||
| 3.6% | 3.87% | 12.89x | 5.05x | 2.67x | 7.87x | 9.02x | 9.66TCr | ||
| 3.08% | 1.57% | 31.62x | 6.88x | 10.19x | 19.94x | 21.32x | 8.72TCr | ||
| -.--% | -.--% | 200.41x | 72.37x | 15.74x | 103.92x | 100.59x | 6.05TCr | ||
| 0.45% | 0.52% | 46.45x | 6.91x | 11.22x | 36.85x | 38.76x | 5.79TCr | ||
| Average | 2.65% | 2.73% | 36.10x | -18.04x | 6.40x | 19.07x | 20.43x | 22.51TCr | |
| Weighted average by Cap. | 2.46% | 2.53% | 30.84x | -38.54x | 7.47x | 18.47x | 19.96x |
- Stock Market
- Equities
- BAYN Stock
- Sector Bayer AG
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















